The syllabus

1.1 Anaphylaxis · <2%

• 1.1.1 General anaphylaxis Written
• 1.1.2 Aspirin idiosyncrasy Written
• 1.1.3 Stinging insect hypersensitivity Written
• 1.1.4 Desensitization therapy
• 1.1.5 Serum sickness

1.2 Asthma · <2%

• 1.2.1 General asthma
• 1.2.2 Exercise- and cold-induced asthma
• 1.2.3 Allergic bronchopulmonary aspergillosis
• 1.2.4 Nasal polyps and aspirin sensitivity
• 1.2.5 Occupational asthma
• 1.2.6 Asthma and pregnancy
• 1.2.7 Asthma mimics (including vocal cord dysfunction)

1.3 Rhinitis, sinusitis, and conjunctivitis · <2%

• 1.3.1 Allergic rhinitis
• 1.3.2 Acute and chronic sinusitis
• 1.3.3 Allergic conjunctivitis
• 1.3.4 Upper airway cough syndrome

1.4 Food allergy · <2%

• 1.4.1 Food allergy

1.5 Urticaria and angioedema · <2%

• 1.5.1 Hereditary angioedema
• 1.5.2 Drug-induced urticaria and angioedema
• 1.5.3 Other causes of urticarial and anaphylaxis
• 1.5.4 Contrast-related allergy

1.6 Skin disorders · <2%

• 1.6.1 Atopic dermatitis
• 1.6.2 Contact dermatitis

1.7 Drug allergy other than drug-induced urticaria and angioedema · <2%

• 1.7.1 Drug allergy other than drug-induced urticaria and angioedema

1.8 Primary immunodeficiency disorders · <2%

• 1.8.1 Primary humoral immunodeficiency
• 1.8.2 Cellular immunodeficiency other than human immunodeficiency virus (HIV) infection
• 1.8.3 Complement deficiency

1.9 Allergic complications of transfusions · <2%

• 1.9.1 Hemolytic transfusions reactions
• 1.9.2 Transfusion-related acute lung injury
• 1.9.3 Transfusion-related urticaria and anaphylaxis

1.10 Autoimmune systemic disorders (including IgG4 related disorders) · <2%

• 1.10.1 Mastocytosis
• 1.10.2 Allergic interstitial nephritis
• 1.10.3 Eosinophilic esophagitis
• 1.10.4 Eosinophilic pneumonia
• 1.10.5 Eosinophilic granulomatosis with polyangiitis
• 1.10.6 Hypersensitivity pneumonitis (extrinsic allergic alveolitis)

2.1 Hypertension · 5%

NOTE: This total includes the Hypertension content listed under Endocrinology, Diabetes, and Metabolism; Nephrology and Urology

• 2.1.1 Essential hypertension
• 2.1.2 Renal (including renal parenchymal, renovascular)
• 2.1.3 Coarctation of the aorta
• 2.1.4 Hypertensive urgency and emergency
• 2.1.5 Undifferentiated hypertension

2.2 Pericardial disease · <2%

• 2.2.1 Pericarditis
• 2.2.2 Pericardial effusion
• 2.2.3 Constrictive pericarditis

2.3 Ischemic heart disease · <2%

• 2.3.1 Stable angina pectoris
• 2.3.2 Acute coronary syndrome (ACS)
• 2.3.3 ACS complications
• 2.3.4 Heart failure from ischemic cardiomyopathy
• 2.3.5 Non-cardiac chest pain
• 2.3.6 Other ischemic heart disease (coronary artery disease, spasm)

2.4 Dysrhythmias and conduction defects · <2%

• 2.4.1 Conduction defects
• 2.4.2 Bradyarrhythmias
• 2.4.3 Tachyarrhythmias
• 2.4.4 Other dysrhythmias (cardiac resuscitation)

2.5 Congenital heart disease in adults · <2%

• 2.5.1 Atrial septal defect and patent foramen ovale
• 2.5.2 Bicuspid aortic valve
• 2.5.3 Other congenital heart disease (patent ductus arteriosus, ventricular septal defect, pulmonic stenosis)

2.6 Valvular heart disease · <2%

• 2.6.1 Aortic stenosis
• 2.6.2 Aortic regurgitation
• 2.6.3 Mitral regurgitation
• 2.6.4 Mitral stenosis
• 2.6.5 Prosthetic heart valve

2.7 Myocardial disease · <2%

• 2.7.1 Heart failure with preserved ejection fraction (HFpEF)
• 2.7.2 Myocarditis
• 2.7.3 Hypertrophic cardiomyopathy with and without obstruction
• 2.7.4 Restrictive cardiomyopathy
• 2.7.5 Dilated cardiomyopathy
• 2.7.6 Cor pulmonale
• 2.7.7 Undifferentiated myocardial disease

2.8 Endocarditis and other cardiovascular infection · <2%

• 2.8.1 Endocarditis
• 2.8.2 Infections of the pericardial space
• 2.8.3 Endocarditis prophylaxis
• 2.8.4 Cardiovascular implantable device infection

2.9 Vascular disease · <2%

• 2.9.1 Carotid artery disease
• 2.9.2 Aorta
• 2.9.3 Peripheral arterial disease
• 2.9.4 Pulmonary vascular disease
• 2.9.5 Venous disease of the lower extremities
• 2.9.6 Superior vena cava syndrome (not due to cancer)

2.10 Syncope · <2%

• 2.10.1 Reflex syncope (vasovagal and situational)
• 2.10.2 Orthostatic hypotension
• 2.10.3 Cardiac syncope (structural and electrical

2.11 Preoperative consultation · <2%

• 2.11.1 No testing required
• 2.11.2 Testing indicated

2.12 Lipid disorders · <2%

• 2.12.1 Lipid disorders

2.13 Antithrombotic therapy in cardiovascular disease · <2%

• 2.13.1 Antithrombotic therapy in cardiovascular disease

2.14 Miscellaneous cardiovascular disease (physical examination findings, murmurs) · <2%

• 2.14.1 Miscellaneous cardiovascular disease (physical examination findings, murmurs)

3.1 Dermatitis (eczemas) · <2%

• 3.1.1 Atopic dermatitis · same lesson as 1.6.1
• 3.1.2 Contact dermatitis · same lesson as 1.6.2
• 3.1.3 Photodermatitis
• 3.1.4 Stasis dermatitis
• 3.1.5 Hand dermatitis
• 3.1.6 Drug eruptions
• 3.1.7 Nummular dermatitis
• 3.1.8 Exfoliative dermatitis (erythroderma, not including mycosis fungoides)
• 3.1.9 Seborrheic dermatitis

3.2 Dermatologic immunology · <2%

• 3.2.1 Urticaria and angioedema
• 3.2.2 Leukocytoclastic vasculitis

3.3 Vascular dermatoses · <2%

• 3.3.1 Erythema multiforme
• 3.3.2 Erythema nodosum
• 3.3.3 Telangiectasia
• 3.3.4 Leg ulcers

3.4 Acne and rosacea · <2%

• 3.4.1 Acne vulgaris
• 3.4.2 Rosacea

3.5 Papulosquamous dermatoses · <2%

• 3.5.1 Psoriasis
• 3.5.2 Pityriasis rosea
• 3.5.3 Lichen planus

3.6 Skin and soft tissue infections · <2%

• 3.6.1 Dermatophytes
• 3.6.2 Herpes zoster and varicella
• 3.6.3 Viral exanthems other than varicella
• 3.6.4 Cellulitis, erypsipelas, and skin abscess
• 3.6.5 Necrotizing soft-tissue infections and gas gangrene
• 3.6.6 Lymphadenitis and lymphangitis
• 3.6.7 Ectoparasites (lice, scabies, and others)

3.7 Vesiculobullous dermatoses · <2%

• 3.7.1 Pemphigus vulgaris
• 3.7.2 Dermatitis herpetiformis

3.8 Pigment disorders · <2%

• 3.8.1 Vitiligo and other hypopigmentation disorders
• 3.8.2 Melasma (chloasma)
• 3.8.3 Acanthosis nigricans
• 3.8.4 Xeroderma pigmentosa

3.9 Photosensitivity dermatoses · <2%

• 3.9.1 Porphyria cutanea tarda
• 3.9.2 Photodermatitis · same lesson as 3.1.3

3.10 Alopecia · <2%

• 3.10.1 Alopecia

3.11 Nodules and tumors of the skin · <2%

• 3.11.1 Seborrheic keratosis
• 3.11.2 Actinic keratosis
• 3.11.3 Warts, corns, and skin tags
• 3.11.4 Squamous cell carcinoma of the skin
• 3.11.5 Basal cell carcinoma of the skin
• 3.11.6 Melanoma and nevi
• 3.11.7 Mycosis fungoides
• 3.11.8 Other nodules or tumors of skin (dermatofibroma)

3.12 Cutaneous manifestations of nutritional deficiencies · <2%

• 3.12.1 Cutaneous manifestations of nutritional deficiencies

3.13 Disorders of the nails · <2%

• 3.13.1 Disorders of the nails

3.14 Environmental injury of skin · <2%

• 3.14.1 Frostbite
• 3.14.2 Burns

3.15 Pressure injuries · <2%

• 3.15.1 Pressure injuries

3.16 Dermatologic emergencies · <2%

• 3.16.1 Dermatologic emergencies

4.1 Adrenal disorders · <2%

• 4.1.1 Adrenal hormonal excess
• 4.1.2 Adrenal insufficiency
• 4.1.3 Adrenal masses and nodules

4.2 Thyroid disorders · <2%

• 4.2.1 Hyperthyroidism
• 4.2.2 Hypothyroidism
• 4.2.3 Thyroiditis (not Hashimoto or peripartum)
• 4.2.4 Thyroid nodules and thyroid cancer
• 4.2.5 Euthyroid sick syndrome
• 4.2.6 Thyroid storm
• 4.2.7 Myxedema coma
• 4.2.8 Thyroid disease in pregnancy, peripartum, or postpartum period

4.3 Endocrine causes of secondary hypertension · <2%

• 4.3.1 Endocrine causes of secondary hypertension

4.4 Lipid disorders · <2%

• 4.4.1 Hypercholesterolemia
• 4.4.2 Hypertriglyceridemia (not including chylomicronemia)
• 4.4.3 Chylomicronemia syndrome
• 4.4.4 Diet and hyperlipidemia

4.5 Ovarian disorders and female reproductive health · <2%

• 4.5.1 Polycystic ovary syndrome
• 4.5.2 Premature ovarian failure
• 4.5.3 Female infertility
• 4.5.4 Hormonal therapy (contraception, postmenopausal replacement therapy, abnormal uterine bleeding)

4.6 Testes and male reproductive health · <2%

• 4.6.1 Male hypogonadism
• 4.6.2 Male infertility
• 4.6.3 Erectile dysfunction
• 4.6.4 Gynecomastia

4.7 Diabetes mellitus · <2%

• 4.7.1 Type 1 diabetes mellitus
• 4.7.2 Type 2 diabetes mellitus
• 4.7.3 Diabetes mellitus and pregnancy
• 4.7.4 Complications of diabetes mellitus

4.8 Disorders of calcium metabolism and bone · <2%

• 4.8.1 Hypercalcemia
• 4.8.2 Hypocalcemia (not including vitamin D deficiency)
• 4.8.3 Hyperphosphatemia
• 4.8.4 Hypophosphatemia
• 4.8.5 Paget disease
• 4.8.6 Osteoporosis
• 4.8.7 Vitamin D deficiency and osteomalacia
• 4.8.8 Chronic kidney disease-mineral and bone disorder

4.9 Hypothalamic disorders · <2%

• 4.9.1 Hypothalamic disorders

4.10 Anterior pituitary disorders · <2%

• 4.10.1 Pituitary tumors
• 4.10.2 Hypopituitarism

4.11 Posterior pituitary and water homeostasis · <2%

• 4.11.1 Hypernatremia
• 4.11.2 Hyponatremia

4.12 Endocrine tumors and endocrine manifestations of tumors · <2%

• 4.12.1 Insulinoma
• 4.12.2 Carcinoid syndrome
• 4.12.3 Other endocrine tumors or manifestations of tumors

4.13 Hypoglycemia not due to insulinoma · <2%

• 4.13.1 Hypoglycemia not due to insulinoma

4.14 Polyglandular autoimmune disorders · <2%

• 4.14.1 Multiple endocrine hypofunction

5.1 Esophageal disease · <2%

• 5.1.1 Gastroesophageal reflux
• 5.1.2 Barrett esophagus
• 5.1.3 Esophageal cancer screening
• 5.1.4 Esophageal motility disorders
• 5.1.5 Medication-induced esophageal disorder
• 5.1.6 Esophageal diverticula
• 5.1.7 Esophageal strictures or webs
• 5.1.8 Gastroesophageal varices
• 5.1.9 Infectious esophagitis (Candida, herpes simplex virus, cytomegalovirus)
• 5.1.10 Mallory-Weiss syndrome
• 5.1.11 Other esophageal disease (eosinophilic esophagitis, esophageal rupture)

5.2 Stomach and duodenal disease · <2%

• 5.2.1 Helicobacter pylori infection
• 5.2.2 Peptic ulcer disease (other than Helicobacter pylori)
• 5.2.3 Gastritis and gastropathy
• 5.2.4 Non-ulcer dyspepsia
• 5.2.5 Disorders of gastric emptying

5.3 Small intestinal disease · <2%

• 5.3.1 Celiac disease
• 5.3.2 Bacterial overgrowth syndrome
• 5.3.3 Short bowel syndrome
• 5.3.4 Ischemic bowel disease
• 5.3.5 Crohn disease including Crohn colitis
• 5.3.6 Gastroenteritis other than antibiotic colitis
• 5.3.7 Other small intestinal disease (diarrhea [osmotic, post-surgical, bile salt-induced, nocturnal], gastric bypass complications)

5.4 Colonic and anorectal disease · <2%

• 5.4.1 Colorectal cancer screening
• 5.4.2 Colon polyposis syndrome and other genetic colon cancer syndromes
• 5.4.3 Diverticular disease
• 5.4.4 Ulcerative colitis
• 5.4.5 Irritable bowel syndrome
• 5.4.6 Hemorrhoids and fissures
• 5.4.7 Antibiotic colitis
• 5.4.8 Acute appendicitis
• 5.4.9 Radiation colitis
• 5.4.10 Other colonic or anorectal disease (constipation, fecal incontinence, neutropenic and lymphocytic colitis)

5.5 Pancreatic disease · <2%

• 5.5.1 Acute pancreatitis
• 5.5.2 Chronic pancreatitis
• 5.5.3 Cystic fibrosis
• 5.5.4 Neuroendocrine tumors of the pancreas
• 5.5.5 Infections of the pancreas and pancreatic abscess
• 5.5.6 Other pancreatic disease

5.6 Biliary tract disease · <2%

• 5.6.1 Cholelithiasis
• 5.6.2 Cholecystitis
• 5.6.3 Choledocholithiasis
• 5.6.4 Cholangitis
• 5.6.5 Primary sclerosing cholangitis
• 5.6.6 Sphincter of Oddi dysfunction

5.7 Liver disease · <2%

• 5.7.1 Viral hepatitis
• 5.7.2 Liver abscess
• 5.7.3 Cirrhosis
• 5.7.4 Drug-induced liver disease other than acetaminophen
• 5.7.5 Autoimmune hepatitis
• 5.7.6 Primary biliary cholangitis
• 5.7.7 Cholestasis
• 5.7.8 Wilson disease
• 5.7.9 Liver disease in pregnancy
• 5.7.10 Hemochromatosis
• 5.7.11 Hepatic vein thrombosis (Budd-Chiari syndrome)
• 5.7.12 Fatty liver and nonalcoholic steatohepatitis
• 5.7.13 Alcoholic hepatitis
• 5.7.14 Fulminant liver failure
• 5.7.15 Gilbert syndrome
• 5.7.16 Hepatocellular carcinoma screening
• 5.7.17 Liver transplantation
• 5.7.18 Other liver disease

5.8 Gastrointestinal complications of HIV infection · <2%

• 5.8.1 Gastrointestinal complications of HIV infection

5.9 Gastrointestinal hemorrhage · <2%

• 5.9.1 Upper gastrointestinal hemorrhage
• 5.9.2 Lower gastrointestinal hemorrhage
• 5.9.3 Hemorrhage of unknown source

6.1 Hypoproliferative anemia · <2%

• 6.1.1 Aplastic anemia
• 6.1.2 Anemia of chronic disease or organ failure (including kidney failure)
• 6.1.3 Iron deficiency anemia
• 6.1.4 Sideroblastic anemia
• 6.1.5 Megaloblastic anemia
• 6.1.6 Lead intoxication

6.2 Hemolytic anemia · <2%

• 6.2.1 Glucose-6-phosphate dehydrogenase deficiency
• 6.2.2 Autoimmune hemolytic anemia
• 6.2.3 Microangiopathic hemolytic anemia
• 6.2.4 Other hemolytic anemia

6.3 Hemoglobinopathies and thalassemias · <2%

• 6.3.1 Thalassemias
• 6.3.2 Hemoglobinopathies

6.4 Leukocyte disorders · <2%

• 6.4.1 Acute leukemia
• 6.4.2 Chronic leukemia
• 6.4.3 Leukocyte disorders (marrow infiltration, myelosuppression, leukopenia, leukocytosis, eosinophilia)

6.5 Platelet disorders · <2%

• 6.5.1 Idiopathic thrombocytopenic purpura
• 6.5.2 Qualitative defects of platelet function (drugs only)
• 6.5.3 Heparin-induced thrombocytopenia (HIT)
• 6.5.4 Essential thrombocythemia

6.6 Coagulation factor disorders and thrombotic disorders · <2%

• 6.6.1 Coagulation factor deficiencies
• 6.6.2 Primary hypercoagulable states (including AT3 deficiency, APC resistance)
• 6.6.3 Antiphospholipid antibody syndrome
• 6.6.4 Undifferentiated thrombotic disorders

6.7 Porphyria · <2%

• 6.7.1 Porphyria

6.8 Myeloproliferative disorders · <2%

• 6.8.1 Polycythemia vera and other erythrocytosis
• 6.8.2 Essential thrombocythemia · same lesson as 6.5.4
• 6.8.3 Agnogenic myeloid metaplasia and myelofibrosis

6.9 Myelodysplastic syndrome · <2%

• 6.9.1 Myelodysplastic syndrome

6.10 Hematologic malignancies · <2%

• 6.10.1 Chronic leukemias
• 6.10.2 Acute leukemia · same lesson as 6.4.1
• 6.10.3 Non-Hodgkin lymphoma
• 6.10.4 Hodgkin disease
• 6.10.5 Plasma cell disorder

6.11 Transfusion medicine (principles and complications) · <2%

• 6.11.1 Indications for transfusion
• 6.11.2 Complications of transfusions

6.12 Hematologic complications of HIV infection · <2%

• 6.12.1 Hematologic complications of HIV infection

6.13 Bone marrow transplantation (late complications only) · <2%

• 6.13.1 Bone marrow transplantation (late complications only)

7.1 Skin and soft tissue infections · <2%

• 7.1.1 Dermatophytes · same lesson as 3.6.1
• 7.1.2 Herpes zoster and varicella · same lesson as 3.6.2
• 7.1.3 Viral exanthems other than varicella · same lesson as 3.6.3
• 7.1.4 Cellulitis
• 7.1.5 Impetigo
• 7.1.6 Necrotizing soft tissue infections and gas gangrene · same lesson as 3.6.5
• 7.1.7 Lymphadenitis and lymphangitis · same lesson as 3.6.6
• 7.1.8 Diabetic foot infections
• 7.1.9 Undifferentiated skin and soft tissue infections

7.2 Central nervous system (CNS) infections · <2%

• 7.2.1 Meningitis
• 7.2.2 Brain abscess
• 7.2.3 Encephalitis
• 7.2.4 Epidural abscess
• 7.2.5 Iatrogenic and postoperative CNS infections
• 7.2.6 Undifferentiated central nervous system infection

7.3 Upper respiratory tract infections · <2%

• 7.3.1 Acute and chronic sinusitis · same lesson as 1.3.2
• 7.3.2 Otitis media and externa
• 7.3.3 Mastoiditis
• 7.3.4 Common cold
• 7.3.5 Pharyngitis
• 7.3.6 Epiglottitis
• 7.3.7 Deep infections of head and neck
• 7.3.8 Other upper respiratory tract infections (pertussis)

7.4 Eye infections · <2%

• 7.4.1 Preseptal cellulitis
• 7.4.2 Conjunctivitis
• 7.4.3 Keratitis
• 7.4.4 Endophthalmitis
• 7.4.5 Uveitis/Iritis
• 7.4.6 Orbital infections

7.5 Lower respiratory tract infections · <2%

• 7.5.1 Bronchitis
• 7.5.2 Pneumonia
• 7.5.3 Lung abscess
• 7.5.4 Tuberculosis (TB)
• 7.5.5 Infections of the pleural space and empyema

7.6 Endocarditis and other cardiovascular infections · <2%

• 7.6.1 Endocarditis · same lesson as 2.8.1
• 7.6.2 Infections of the pericardial space · same lesson as 2.8.2
• 7.6.3 Endocarditis prophylaxis · same lesson as 2.8.3
• 7.6.4 Suppurative thrombophlebitis
• 7.6.5 Catheter-related infections
• 7.6.6 Device and pocket infections

7.7 Hepatic infections · <2%

• 7.7.1 Viral hepatitis · same lesson as 5.7.1
• 7.7.2 Liver abscess · same lesson as 5.7.2
• 7.7.3 Cholecystitis · same lesson as 5.6.2
• 7.7.4 Cholangitis · same lesson as 5.6.4

7.8 Enteric infections · <2%

• 7.8.1 Esophagitis (Candida, herpes simplex virus, cytomegalovirus)
• 7.8.2 Gastroenteritis
• 7.8.3 Infections of the pancreas and pancreatic abscess · same lesson as 5.5.5
• 7.8.4 Bacterial peritonitis
• 7.8.5 Intra-abdominal abscess other than liver or pancreas abscess
• 7.8.6 Acquired immunodeficiency syndrome (AIDS) and

7.9 human immunodeficiency virus (HIV) infection · <2%

• 7.9.1 Transmission and prevention of HIV
• 7.9.2 Prevention of opportunistic infections
• 7.9.3 Immune reconstitution inflammatory syndrome
• 7.9.4 Neurologic complications of HIV infection
• 7.9.5 Pulmonary complications of HIV infection
• 7.9.6 Gastrointestinal complications of HIV infection · same lesson as 5.8.1
• 7.9.7 Hematologic complications of HIV infection · same lesson as 6.12.1
• 7.9.8 Oncologic complications of HIV infection
• 7.9.9 Rheumatologic complications of HIV infection
• 7.9.10 Cardio-metabolic complications of HIV therapy and infection
• 7.9.11 Oral complications of HIV infection

7.10 Sexually transmitted diseases and infections of reproductive organs · <2%

• 7.10.1 Urethritis
• 7.10.2 Genital ulcers
• 7.10.3 Vulvovaginitis
• 7.10.4 Cervicitis
• 7.10.5 Epididymitis
• 7.10.6 Salpingitis and other infections of female pelvis
• 7.10.7 Syphilis
• 7.10.8 Human papillomavirus and anogenital warts
• 7.10.9 Undifferentiated sexually transmitted diseases

7.11 Urinary tract infections · <2%

• 7.11.1 Asymptomatic bacteriuria
• 7.11.2 Cystitis and pyelonephritis
• 7.11.3 Perinephric abscess
• 7.11.4 Prostatitis
• 7.11.5 Epididymitis · same lesson as 7.10.5

7.12 Infectious arthritis · <2%

• 7.12.1 Infectious arthritis

7.13 Osteomyelitis · <2%

• 7.13.1 Osteomyelitis

7.14 Bacteremia and sepsis syndrome · <2%

• 7.14.1 Fever and neutropenia
• 7.14.2 Systemic inflammatory response syndrome (SIRS) and septic shock
• 7.14.3 Toxic shock syndrome
• 7.14.4 Undifferentiated bacteremia and sepsis syndromes

7.15 Rheumatic fever · <2%

• 7.15.1 Rheumatic fever

7.16 Poststreptococcal glomerulonephritis · <2%

• 7.16.1 Poststreptococcal glomerulonephritis

7.17 Procedure-and device-associated infections · <2%

• 7.17.1 Procedure-and device-associated infections

7.18 Nosocomial infections · <2%

• 7.18.1 Infection control including isolation
• 7.18.2 Hospital-acquired infections and prevention
• 7.18.3 Needlestick injury and postexposure prophylaxis
• 7.18.4 Undifferentiated nosocomial infections

7.19 Prevention of infectious disease · <2%

• 7.19.1 Immunization
• 7.19.2 Infection prevention and control including isolation precautions
• 7.19.3 Needlestick injury and postexposure prophylaxis · same lesson as 7.18.3
• 7.19.4 Travel-related illness prevention
• 7.19.5 Other preventions of infectious disease

7.20 Travel-related illness (fever, rash, diarrhea, and other) · <2%

• 7.20.1 Travel-related illness (fever, rash, diarrhea, and other)

7.21 Infectious disease outbreaks · <2%

• 7.21.1 Infectious disease outbreaks

7.22 Specific causative organisms · <2%

• 7.22.1 Viral diseases
• 7.22.2 Prion diseases
• 7.22.3 Rickettsioses and ehrlichioses
• 7.22.4 Bacterial diseases
• 7.22.5 Chlamydial diseases
• 7.22.6 Mycoplasmal diseases
• 7.22.7 Mycoses (fungal infections)
• 7.22.8 Protozoan and helminthic diseases (including malaria)
• 7.22.9 Ectoparasites (including lice and scabies)
• 7.22.10 Vector-borne diseases

7.23 Fever of unknown origin · <2%

• 7.23.1 Fever of unknown origin

8.1 Primarily epidemiology · <2%

• 8.1.1 Primarily epidemiology

8.2 Primarily ethics · <2%

• 8.2.1 Primarily ethics

8.3 Primarily safety and quality improvement · <2%

• 8.3.1 Primarily safety and quality improvement

9.1 Acute kidney injury · <2%

• 9.1.1 Hypotension- or shock-induced acute kidney injury
• 9.1.2 Toxic kidney injury
• 9.1.3 Rhabdomyolysis
• 9.1.4 Hepatorenal syndrome
• 9.1.5 Disseminated atheroembolism (cholesterol emboli syndrome)
• 9.1.6 Other acute kidney injury
• 9.1.7 Myeloma-induced kidney disease

9.2 Chronic kidney disease · <2%

• 9.2.1 Kidney dialysis
• 9.2.2 Kidney transplantation
• 9.2.3 Strategies to prevent progression of chronic kidney disease
• 9.2.4 Undifferentiated chronic kidney disease

9.3 Tubulointerstitial disease · <2%

• 9.3.1 Tubulointerstitial disease

9.4 Glomerular disorders · <2%

• 9.4.1 Lupus nephritis and glomerulonephritis
• 9.4.2 Minimal change disease
• 9.4.3 Focal and segmental glomerulosclerosis
• 9.4.4 Membranous nephropathy
• 9.4.5 Membranoproliferative glomerulonephritis
• 9.4.6 IgA nephropathy
• 9.4.7 Anti-glomerular basement membrane syndrome
• 9.4.8 Vasculitis and the kidney
• 9.4.9 Other glomerular disorders (post-infectious,hematuria)

9.5 Hypertension · 5%

NOTE: This total includes the Hypertension content listed under Cardiovascular Disease

• 9.5.1 Essential hypertension · same lesson as 2.1.1
• 9.5.2 Primary aldosteronism and mineralocorticoid excess
• 9.5.3 Renovascular hypertension

9.6 Urinary tract infections · <2%

• 9.6.1 Asymptomatic bacteriuria · same lesson as 7.11.1
• 9.6.2 Cystitis and pyelonephritis · same lesson as 7.11.2
• 9.6.3 Perinephric abscess · same lesson as 7.11.3
• 9.6.4 Prostatitis · same lesson as 7.11.4
• 9.6.5 Epididymitis · same lesson as 7.10.5

9.7 Nephrolithiasis · <2%

• 9.7.1 Nephrolithiasis

9.8 Other kidney disorders · <2%

• 9.8.1 Renal vein thrombosis
• 9.8.2 Obstructive uropathy (acute or chronic)
• 9.8.3 Diabetic nephropathy
• 9.8.4 Cystic kidney disease (polycystic, medullary sponge, medullary cystic)

9.9 Urologic cancer screening · <2%

• 9.9.1 Urologic cancer screening

9.10 Prostate disorders · <2%

• 9.10.1 Benign prostatic hyperplasia
• 9.10.2 Undifferentiated prostate disorders

9.11 Other urologic disorders · <2%

• 9.11.1 Testicular torsion
• 9.11.2 Scrotal and testicular nodules or masses other than testicular carcinoma
• 9.11.3 Erectile dysfunction · same lesson as 4.6.3

9.12 Urinary incontinence · <2%

• 9.12.1 Urinary incontinence in women
• 9.12.2 Urinary incontinence in men

9.13 Water and electrolyte balance · <2%

• 9.13.1 Hypernatremia · same lesson as 4.11.1
• 9.13.2 Hyponatremia · same lesson as 4.11.2
• 9.13.3 Hypokalemia
• 9.13.4 Hyperkalemia
• 9.13.5 Hypercalcemia and hypercalciuria
• 9.13.6 Hypocalcemia
• 9.13.7 Hyperphosphatemia · same lesson as 4.8.3
• 9.13.8 Hypophosphatemia · same lesson as 4.8.4
• 9.13.9 Hypermagnesemia
• 9.13.10 Hypomagnesemia
• 9.13.11 Metabolic acidosis
• 9.13.12 Metabolic alkalosis
• 9.13.13 Respiratory acidosis
• 9.13.14 Respiratory alkalosis
• 9.13.15 Mixed acid-base disturbance

9.14 Hematuria · <2%

• 9.14.1 Glomerular cause
• 9.14.2 Non-glomerular cause

10.1 Seizures · <2%

• 10.1.1 Seizures

10.2 Cerebrovascular disease (without specific diagnosis)

• 10.2.1 Transient ischemic attack
• 10.2.2 Stroke
• 10.2.3 Cavernous sinus thrombosis
• 10.2.4 Other cerebrovascular disease (less common anatomic locations, mechanisms)

10.3 Headache and facial pain · <2%

• 10.3.1 Primary headache
• 10.3.2 Cluster headache
• 10.3.3 Secondary headache and facial pain

10.4 Nerve root syndromes and mechanical lesions of the spine · <2%

• 10.4.1 Cervical root disease
• 10.4.2 Lumbar disc herniation, lumbosacral radiculopathy, sciatica
• 10.4.3 Spinal stenosis

10.5 Peripheral neuropathy · <2%

• 10.5.1 Acute inflammatory demyelinating polyneuropathy (Guillain-Barre syndrome)
• 10.5.2 Carpal tunnel syndrome and other entrapment neuropathies
• 10.5.3 Meralgia paresthetica
• 10.5.4 Fibular (peroneal) neuropathy
• 10.5.5 Diabetic neuropathy
• 10.5.6 Postherpetic neuralgia
• 10.5.7 Drugs and toxins

10.6 Cranial neuropathy · <2%

• 10.6.1 Bell palsy and other facial nerve disorders
• 10.6.2 Disorders of eye movement from cranial neuropathy (III, IV, VI)
• 10.6.3 Vestibular neuronitis (acute labyrinthitis)

10.7 Disorders of cerebral function · <2%

• 10.7.1 Dementia
• 10.7.2 Aphasia
• 10.7.3 Medical causes of delirium

10.8 Movement disorders · <2%

• 10.8.1 Parkinson disease and parkinsonism
• 10.8.2 Essential tremor
• 10.8.3 Other movement disorders (including other tremors, dystonias, chorea, myoclonus, tardive dyskinesia, restless leg syndrome)

10.9 Central nervous system (CNS) infections · <2%

• 10.9.1 Meningitis · same lesson as 7.2.1
• 10.9.2 Brain abscess · same lesson as 7.2.2
• 10.9.3 Encephalitis · same lesson as 7.2.3
• 10.9.4 Epidural abscess · same lesson as 7.2.4
• 10.9.5 Neurologic complications of HIV infection · same lesson as 7.9.4
• 10.9.6 Progressive multifocal leukoencephalopathy
• 10.9.7 Autoimmune encephalitis

10.10 Central nervous system (CNS) tumors · <2%

• 10.10.1 Brain tumors
• 10.10.2 Spinal cord tumors and compression
• 10.10.3 Carcinomatous meningitis
• 10.10.4 Paraneoplastic neurologic syndromes

10.11 Diseases of muscle and neuromuscular junction · <2%

• 10.11.1 Myasthenia gravis and Lambert-Eaton syndrome
• 10.11.2 Polymyositis and dermatomyositis
• 10.11.3 Drug-induced myopathy
• 10.11.4 Myotonic dystrophy and other inherited myopathies
• 10.11.5 Other diseases of muscle and neuromuscular junction

10.12 Multiple sclerosis and other demyelinating diseases · <2%

• 10.12.1 Multiple sclerosis and other demyelinating diseases

10.13 Other neurologic disorders · <2%

• 10.13.1 Neurocutaneous syndromes
• 10.13.2 Head injury
• 10.13.3 Spinal cord injury and disorders
• 10.13.4 Idiopathic intracranial hypertension
• 10.13.5 Motor neuron disease
• 10.13.6 Neuroleptic malignant syndrome
• 10.13.7 Cerebellar ataxias

10.14 Neuro-ophthalmology · <2%

• 10.14.1 Optic nerve disorders, including optic neuritis
• 10.14.2 Pupillary abnormalities including anisocoria
• 10.14.3 Disorders of eye movement
• 10.14.4 Papilledema

10.15 Miscellaneous neurologic disorders · <2%

• 10.15.1 Vertigo
• 10.15.2 Gait and balance disorders

11.1 Diseases of the vulva and external genitalia · <2%

• 11.1.1 Diseases of the vulva and external genitalia

11.2 Breast disorders · <2%

• 11.2.1 Breast nodules
• 11.2.2 Mastitis and breast-feeding
• 11.2.3 Other breast disorders (cyclic pain, nipple discharge)

11.3 Ovarian disorders · <2%

• 11.3.1 Polycystic ovary syndrome · same lesson as 4.5.1
• 11.3.2 Ovarian cysts
• 11.3.3 Ovarian cancer

11.4 Uterine disorders · <2%

• 11.4.1 Uterine fibroids
• 11.4.2 Endometriosis
• 11.4.3 Endometrial cancer
• 11.4.4 Cervical cancer

11.5 Vaginal disorders other than vulvovaginitis · <2%

• 11.5.1 Vaginal disorders other than vulvovaginitis

11.6 Pregnancy · <2%

• 11.6.1 Hypertension in pregnancy
• 11.6.2 Asthma and pregnancy · same lesson as 1.2.6
• 11.6.3 Hyperthyroidism during pregnancy or peripartum period
• 11.6.4 Liver disease in pregnancy · same lesson as 5.7.9
• 11.6.5 Peripartum cardiomyopathy
• 11.6.6 Ectopic pregnancy
• 11.6.7 Diabetes mellitus and pregnancy · same lesson as 4.7.3
• 11.6.8 Urinary tract infections in pregnancy
• 11.6.9 Nutritional deficiencies

11.7 Menstrual disorders · <2%

• 11.7.1 Dysmenorrhea
• 11.7.2 Amenorrhea
• 11.7.3 Abnormal uterine bleeding

11.8 Menopause - management, risks, and benefits of therapy · <2%

• 11.8.1 Menopause - management, risks, and benefits of therapy

11.9 Family planning and reproductive health · <2%

• 11.9.1 Family planning and reproductive health

11.10 Sexually transmitted diseases and infections of reproductive organs · <2%

• 11.10.1 Sexually transmitted diseases and infections of reproductive organs

12.1 Lung cancer (clinical presentation and diagnosis) · <2%

• 12.1.1 Lung cancer (clinical presentation and diagnosis)

12.2 Breast cancer · <2%

• 12.2.1 Breast cancer

12.3 Neoplasms of the head and neck · <2%

• 12.3.1 Thyroid nodules and thyroid cancer · same lesson as 4.2.4
• 12.3.2 Other neoplasms of the head and neck (not thyroid cancer)

12.4 Gastrointestinal or hepatic cancer · <2%

• 12.4.1 Esophageal carcinoma
• 12.4.2 Stomach cancer
• 12.4.3 Colorectal cancer
• 12.4.4 Pancreatic carcinoma other than pancreatic endocrine tumors
• 12.4.5 Hepatocellular carcinoma
• 12.4.6 Gallbladder cancer
• 12.4.7 Anal cancer

12.5 Urologic cancer · <2%

• 12.5.1 Renal cell carcinoma
• 12.5.2 Bladder carcinoma
• 12.5.3 Prostate carcinoma
• 12.5.4 Testicular carcinoma and tumors

12.6 Gynecologic cancer · <2%

• 12.6.1 Ovarian cancer · same lesson as 11.3.3
• 12.6.2 Endometrial cancer · same lesson as 11.4.3
• 12.6.3 Cervical cancer · same lesson as 11.4.4
• 12.6.4 Vulvar cancer

12.7 Bone tumors · <2%

• 12.7.1 Bone tumors

12.8 Central nervous system (CNS) tumors · <2%

• 12.8.1 Brain tumors (primary or metastatic)
• 12.8.2 Spinal cord tumors and compression · same lesson as 10.10.2
• 12.8.3 Carcinomatous meningitis · same lesson as 10.10.3

12.9 Skin cancer · <2%

• 12.9.1 Squamous cell carcinoma of the skin · same lesson as 3.11.4
• 12.9.2 Basal cell carcinoma of the skin · same lesson as 3.11.5
• 12.9.3 Melanoma and nevi · same lesson as 3.11.6
• 12.9.4 Mycosis fungoides · same lesson as 3.11.7

12.10 Hematologic malignancies · <2%

• 12.10.1 Chronic leukemia · same lesson as 6.4.2
• 12.10.2 Acute leukemia · same lesson as 6.4.1
• 12.10.3 Non-Hodgkin lymphoma · same lesson as 6.10.3
• 12.10.4 Hodgkin disease · same lesson as 6.10.4
• 12.10.5 Plasma cell disorder · same lesson as 6.10.5

12.11 Soft tissue cancer · <2%

• 12.11.1 Soft tissue cancer

12.12 Oncologic complications of HIV infection · <2%

• 12.12.1 Oncologic complications of HIV infection · same lesson as 7.9.8

12.13 Cancer of unknown primary · <2%

• 12.13.1 Cancer of unknown primary

12.14 Cancer prevention · <2%

• 12.14.1 Smoking cessation
• 12.14.2 Environmental carcinogens
• 12.14.3 Inherited cancer risk
• 12.14.4 Lifestyle interventions

12.15 Oncologic emergencies · <2%

• 12.15.1 Superior vena cava syndrome
• 12.15.2 Fever and neutropenia · same lesson as 7.14.1
• 12.15.3 Brain tumors
• 12.15.4 Spinal cord tumors and compression · same lesson as 10.10.2
• 12.15.5 Cardiac tamponade from neoplastic pericarditis
• 12.15.6 Tumor lysis syndrome
• 12.15.7 Hypercalcemia

12.16 Complications of cancer and its treatment · <2%

• 12.16.1 Pain (including neuropathy)
• 12.16.2 Dyspnea
• 12.16.3 Paraneoplastic syndromes
• 12.16.4 Lymphedema
• 12.16.5 Nausea, vomiting, diarrhea, constipation
• 12.16.6 Cardiotoxicity
• 12.16.7 Radiation toxicity
• 12.16.8 Immunotherapy
• 12.16.9 Other complications of cancer treatment

12.17 Cancer survivorship · <2%

• 12.17.1 Surveillance
• 12.17.2 Second malignancies
• 12.17.3 Psychosocial and financial considerations

13.1 Conjunctivitis · <1%

• 13.1.1 Viral conjunctivitis
• 13.1.2 Bacterial conjunctivitis
• 13.1.3 Allergic conjunctivitis · same lesson as 1.3.3
• 13.1.4 Other conjunctivitis (keratoconjunctivitis sicca [dry eyes], undifferentiated)

13.2 Glaucoma · <1%

• 13.2.1 Glaucoma

13.3 Cataracts · <1%

• 13.3.1 Cataracts

13.4 Diseases of the cornea · <1%

• 13.4.1 Corneal abrasion
• 13.4.2 Keratitis (infections of the cornea)

13.5 Neuro-ophthalmology · <1%

• 13.5.1 Optic nerve disorders, including optic neuritis · same lesson as 10.14.1
• 13.5.2 Pupillary abnormalities, including anisocoria · same lesson as 10.14.2
• 13.5.3 Disorders of eye movement · same lesson as 10.14.3
• 13.5.4 Papilledema · same lesson as 10.14.4

13.6 Retinal disease · <1%

• 13.6.1 Macular degeneration
• 13.6.2 Retinal detachment
• 13.6.3 Diabetic retinopathy
• 13.6.4 Amaurosis fugax
• 13.6.5 Temporal arteritis
• 13.6.6 Roth spot

13.7 Uveitis · <1%

• 13.7.1 Uveitis

13.8 Miscellaneous ophthalmologic disorders · <1%

• 13.8.1 Episcleritis and scleritis
• 13.8.2 Preseptal cellulitis · same lesson as 7.4.1
• 13.8.3 Endophthalmitis · same lesson as 7.4.4
• 13.8.4 Orbital infections · same lesson as 7.4.6

14.1 Disorders of the nose and paranasal sinuses · <1%

• 14.1.1 Allergic rhinitis · same lesson as 1.3.1
• 14.1.2 Acute and chronic sinusitis · same lesson as 1.3.2
• 14.1.3 Disturbances of taste and smell
• 14.1.4 Epistaxis

14.2 Diseases of the ear · <1%

• 14.2.1 Benign paroxysmal positional vertigo
• 14.2.2 Vestibular neuronitis and acute labyrinthitis
• 14.2.3 Meniere disease
• 14.2.4 Acoustic neuroma
• 14.2.5 Presbycusis and other hearing loss
• 14.2.6 Otitis media and externa · same lesson as 7.3.2
• 14.2.7 Cholesteatoma
• 14.2.8 Other disorders of the ear and mastoid

14.3 Diseases of the oral cavity, pharynx, and salivary glands · <1%

• 14.3.1 Pharyngitis · same lesson as 7.3.5
• 14.3.2 Epiglottitis · same lesson as 7.3.6
• 14.3.3 Deep infections of head and neck · same lesson as 7.3.7
• 14.3.4 Parotid disease
• 14.3.5 Diseases of the oral mucosa and the tongue
• 14.3.6 Other disorders of the oral cavity, pharynx, or salivary glands

14.4 Diseases of the larynx and airway · <1%

• 14.4.1 Diseases of the larynx and airway

15.1 Mood disorders · <2%

• 15.1.1 Depression and suicide
• 15.1.2 Bipolar disorder
• 15.1.3 Other mood disorders (psychogenic erectile dysfunction, premenstrual dysphoric disorder)

15.2 Eating disorders -(not including obesity) · <2%

• 15.2.1 Anorexia nervosa
• 15.2.2 Bulimia

15.3 Substance use disorder · <2%

• 15.3.1 Substance use disorder

15.4 Schizophrenia and delusional (paranoid) disorders · <2%

• 15.4.1 Complications of drug therapy
• 15.4.2 Delusional disorder, somatic type

15.5 Anxiety disorders · <2%

• 15.5.1 Obsessive-compulsive disorder
• 15.5.2 Phobias
• 15.5.3 Post-traumatic stress disorders
• 15.5.4 Generalized anxiety disorder
• 15.5.5 Panic disorder

15.6 Somatoform disorders · <2%

• 15.6.1 Somatic symptom disorder
• 15.6.2 Hypochondriasis
• 15.6.3 Conversion disorders

15.7 Sexual disorders and gender dysphoria · <2%

• 15.7.1 Sexual disorders and gender dysphoria

15.8 Sleep disorders · <2%

• 15.8.1 Insomnia
• 15.8.2 Narcolepsy

15.9 Factitious disorders · <2%

• 15.9.1 Factitious disorders

15.10 Personality disorders · <2%

• 15.10.1 Personality disorders

15.11 Neuroleptic malignant disorder · <2%

• 15.11.1 Neuroleptic malignant disorder

16.1 Obstructive airway disease · 2.5%

• 16.1.1 General asthma · same lesson as 1.2.1
• 16.1.2 Chronic bronchitis and emphysema

16.2 Occupational and environmental lung disease · <2%

• 16.2.1 Organic inhalations (hypersensitivity pneumonitis)
• 16.2.2 Inorganic inhalations (pneumoconiosis)
• 16.2.3 Occupational asthma · same lesson as 1.2.5
• 16.2.4 High-altitude illness
• 16.2.5 Carbon monoxide poisoning

16.3 Restrictive lung disease other than interstitial lung and pleural disease · <2%

• 16.3.1 Pulmonary complications of obesity
• 16.3.2 Chest wall disorders
• 16.3.3 Neuromuscular disorders
• 16.3.4 Undifferentiated restrictive lung disease

16.4 Interstitial lung disease · <2%

• 16.4.1 Idiopathic pulmonary fibrosis
• 16.4.2 Sarcoidosis
• 16.4.3 Radiation pneumonitis
• 16.4.4 Drug-induced interstitial lung disease
• 16.4.5 Connective tissue disorders and vasculitis
• 16.4.6 Eosinophilic pneumonia · same lesson as 1.10.4
• 16.4.7 Anti-glomerular basement membrane syndrome · same lesson as 9.4.7

16.5 Pulmonary vascular disease · <2%

• 16.5.1 Pulmonary embolism
• 16.5.2 Idiopathic pulmonary arterial hypertension
• 16.5.3 Cor pulmonale · same lesson as 2.7.6
• 16.5.4 Superior vena cava syndrome · same lesson as 12.15.1
• 16.5.5 Hepatopulmonary syndrome

16.6 Pleural disease · <2%

• 16.6.1 Noninfectious pleural effusion
• 16.6.2 Infections of the pleural space and empyema · same lesson as 7.5.5
• 16.6.3 Pneumothorax

16.7 Lower respiratory tract infections · <2%

• 16.7.1 Bronchitis · same lesson as 7.5.1
• 16.7.2 Pneumonia · same lesson as 7.5.2
• 16.7.3 Lung abscess · same lesson as 7.5.3
• 16.7.4 Tuberculosis
• 16.7.5 Infection of the pleural space and empyema

16.8 Bronchiectasis · <2%

• 16.8.1 Bronchiectasis

16.9 Congenital lung disease · <2%

• 16.9.1 Cystic fibrosis · same lesson as 5.5.3
• 16.9.2 Alpha-1-antitrypsin deficiency

16.10 Acute respiratory distress syndrome (ARDS) · <2%

• 16.10.1 Fat embolism
• 16.10.2 Transfusion-related acute lung injury · same lesson as 1.9.2
• 16.10.3 Acute respiratory distress syndrome (not including fat embolism)

16.11 Lung cancer · <2%

• 16.11.1 Paraneoplastic syndromes · same lesson as 12.16.3
• 16.11.2 Undifferentiated lung cancer

16.12 Sleep medicine · <2%

• 16.12.1 Obesity-hypoventilation syndrome
• 16.12.2 Obstructive sleep apnea
• 16.12.3 Insomnia · same lesson as 15.8.1
• 16.12.4 Parasomnia

16.13 Management of ventilators · <2%

• 16.13.1 Management of ventilators

16.14 Pulmonary complications of HIV infection · <2%

• 16.14.1 Pulmonary complications of HIV infection · same lesson as 7.9.5

16.15 Evaluation of common pulmonary symptoms · 2.5%

• 16.15.1 Cough
• 16.15.2 Dyspnea
• 16.15.3 Hemoptysis
• 16.15.4 Solitary pulmonary nodule

16.16 Miscellaneous pulmonary disorders (indications for spirometry) · <2%

• 16.16.1 Miscellaneous pulmonary disorders (indications for spirometry)

17.1 Crystal-induced arthropathy · <2%

• 17.1.1 Gout
• 17.1.2 Pseudogout
• 17.1.3 Hydroxyapatite deposition disease

17.2 Regional musculoskeletal syndromes · <2%

• 17.2.1 Back pain
• 17.2.2 Shoulder syndromes
• 17.2.3 Elbow syndromes
• 17.2.4 Wrist and hand syndromes
• 17.2.5 Hip and pelvic pain
• 17.2.6 Knee syndromes
• 17.2.7 Foot and ankle syndromes
• 17.2.8 Other bursitis

17.3 Spondyloarthropathies · <2%

• 17.3.1 Ankylosing spondylitis
• 17.3.2 Reactive arthritis
• 17.3.3 Psoriatic arthritis
• 17.3.4 Enteropathic arthritis including arthritis with inflammatory bowel disease
• 17.3.5 Other spondyloarthropathies

17.4 Rheumatoid arthritis · <2%

• 17.4.1 General clinical presentation: Skeletal disease
• 17.4.2 Systemic manifestations
• 17.4.3 Adverse effects of antirheumatic drugs
• 17.4.4 Other topics in rheumatoid arthritis

17.5 Systemic lupus erythematosus (SLE) · <2%

• 17.5.1 General clinical presentation
• 17.5.2 Specific organ system complications
• 17.5.3 Discoid lupus and other cutaneous manifestations
• 17.5.4 Drug-induced lupus
• 17.5.5 Other topics in systemic lupus erythematosus

17.6 Systemic sclerosis · <2%

• 17.6.1 Scleroderma, generalized
• 17.6.2 CREST syndrome
• 17.6.3 Scleroderma and interstitial lung disease
• 17.6.4 Raynaud phenomenon

17.7 Vasculitis · <2%

• 17.7.1 Polyarteritis nodosa
• 17.7.2 Eosinophilic granulomatosis with polyangiitis · same lesson as 1.10.5
• 17.7.3 Leukocytoclastic vasculitis · same lesson as 3.2.2
• 17.7.4 Large-vessel vasculitis
• 17.7.5 ANCA-associated vasculitis

17.8 Other primary rheumatic disorders · <2%

• 17.8.1 Dermatomyositis and polymyositis
• 17.8.2 Relapsing polychondritis
• 17.8.3 Behçet disease
• 17.8.4 Rheumatic fever · same lesson as 7.15.1
• 17.8.5 Sjögren syndrome
• 17.8.6 Fibromyalgia
• 17.8.7 Juvenile rheumatoid arthritis
• 17.8.8 Adult Still disease
• 17.8.9 Marfan and Ehlers-Danlos syndromes
• 17.8.10 Scoliosis
• 17.8.11 Arthropathy of hemochromatosis

17.9 Infectious arthritis · <2%

• 17.9.1 Infectious arthritis · same lesson as 7.12.1

17.10 Metabolic and other bone disease · <2%

• 17.10.1 Hyperparathyroidism
• 17.10.2 Paget disease of bone
• 17.10.3 Avascular necrosis and osteonecrosis
• 17.10.4 Osteogenesis imperfecta

17.11 Osteoarthritis · <2%

• 17.11.1 Osteoarthritis

17.12 Sports injuries and trauma · <2%

• 17.12.1 Sports injuries and trauma

17.13 Charcot-Marie-Tooth Disease · <2%

• 17.13.1 Charcot-Marie-Tooth Disease

17.14 Mixed connective tissue disease · <2%

• 17.14.1 Mixed connective tissue disease

17.15 Select topics in Rheumatology · <2%

• 17.15.1 Select topics in Rheumatology

18.1 Pressure injuries · <2%

• 18.1.1 Pressure injuries · same lesson as 3.15.1

18.2 Venous ulcers and chronic wounds · <2%

• 18.2.1 Venous ulcers and chronic wounds

18.3 End-of-life and palliative care of the elderly · <2%

• 18.3.1 End-of-life and palliative care of the elderly

18.4 Ethics in the elderly · <2%

• 18.4.1 Assessment of decisional capacity and competency and surrogate decision-making in the elderly

18.5 Constipation in the elderly · <2%

• 18.5.1 Constipation in the elderly

18.6 Disorders of swallowing in the elderly · <2%

• 18.6.1 Disorders of swallowing in the elderly

18.7 Urinary tract infections in the elderly · <2%

• 18.7.1 Urinary tract infections in the elderly

18.8 Incontinence in the elderly · <2%

• 18.8.1 Incontinence in the elderly

18.9 Dementia in the elderly · <2%

• 18.9.1 Dementia in the elderly

18.10 Delirium in the elderly · <2%

• 18.10.1 Delirium in the elderly

18.11 Dizziness and vertigo in the elderly · <2%

• 18.11.1 Dizziness and vertigo in the elderly

18.12 Nutrition in the elderly · <2%

• 18.12.1 Nutrition in the elderly

18.13 Ophthalmology in the elderly · <2%

• 18.13.1 Cataracts · same lesson as 13.3.1
• 18.13.2 Age-related macular degeneration
• 18.13.3 Ischemic optic nerve or retinal disease other than giant cell arteritis
• 18.13.4 Glaucoma · same lesson as 13.2.1

18.14 Psychiatry in the elderly · <2%

• 18.14.1 Depression in the elderly
• 18.14.2 Sleep disorders in the elderly
• 18.14.3 Neuropsychological testing of the elderly

18.15 Hip fracture in the elderly · <2%

• 18.15.1 Hip fracture in the elderly

18.16 Common foot problems in the elderly · <2%

• 18.16.1 Common foot problems in the elderly

18.17 Principles of the geriatric assessment · <2%

• 18.17.1 Principles of the geriatric assessment

18.18 Rehabilitation and the elderly · <2%

• 18.18.1 Rehabilitation and the elderly

18.19 Other primary geriatric topics · <2%

• 18.19.1 Clinical pharmacology and aging
• 18.19.2 Epidemiology and aging
• 18.19.3 Nursing home care
• 18.19.4 Home care
• 18.19.5 Presbycusis and hearing loss in the elderly
• 18.19.6 Elder mistreatment
• 18.19.7 Falls
• 18.19.8 Sexual function in the elderly
• 18.19.9 January 2026